Robert F. Roscigno
Presidente en Robert F. Roscigno Phd Consulting LLC .
Perfil
Robert F.
Roscigno currently works at Robert F.
Roscigno Phd Consulting LLC, as President.
Dr. Roscigno also formerly worked at United Therapeutics Corp., as Director & Senior VP-Commercial Development, Liquidia Technologies, Inc., as Senior Vice President-Product Development from 2017 to 2020, Vero Biotech LLC, as Executive Vice President-Global Clinical Affairs from 2013 to 2015, and Lung Biotechnology PBC, as President & Chief Operating Officer from 2005 to 2007.
Dr. Roscigno received his doctorate degree from Duke University and undergraduate degree from Trinity College (Connecticut).
Cargos activos de Robert F. Roscigno
| Empresas | Cargo | Inicio |
|---|---|---|
| Robert F. Roscigno Phd Consulting LLC | Presidente | - |
Antiguos cargos conocidos de Robert F. Roscigno.
| Empresas | Cargo | Fin |
|---|---|---|
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Corporate Officer/Principal | 01/07/2020 |
Vero Biotech LLC
 Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | Corporate Officer/Principal | 01/09/2015 |
Lung Biotechnology PBC
 Lung Biotechnology PBC Pharmaceuticals: MajorHealth Technology Lung Biotechnology PBC develops pharmaceutical products. It specializes in clinical trials, lung perfusion, and XenoLung. The company was founded by Martine Rothblatt and is headquartered in Silver Spring, MD. | Presidente | 01/07/2007 |
| UNITED THERAPEUTICS CORPORATION | Director/Miembro de la Junta | - |
Formación de Robert F. Roscigno.
| Duke University | Doctorate Degree |
| Trinity College (Connecticut) | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| Empresas privadas | 4 |
|---|---|
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Health Technology |
Vero Biotech LLC
Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | Health Technology |
Lung Biotechnology PBC
Lung Biotechnology PBC Pharmaceuticals: MajorHealth Technology Lung Biotechnology PBC develops pharmaceutical products. It specializes in clinical trials, lung perfusion, and XenoLung. The company was founded by Martine Rothblatt and is headquartered in Silver Spring, MD. | Health Technology |
| Robert F. Roscigno Phd Consulting LLC |
- Bolsa de valores
- Insiders
- Robert F. Roscigno
